PursueCare

About PursueCare

PursueCare is a telehealth provider focused on addiction recovery and mental health services, founded in 2019 by Nicholas Mercadante. A former healthcare attorney, Mercadante's experience with the healthcare system, including a personal journey with a GI condition, and his work in behavioral health and telehealth, shaped his mission to dismantle barriers to addiction treatment through technology. The company was established to address the critical gaps in care, particularly for underserved and remote communities, by providing accessible and private treatment.

The company operates a virtual clinic through a proprietary mobile application, offering a comprehensive suite of services for individuals with substance use disorders (SUD), including for opioids, alcohol, and stimulants, as well as co-occurring mental health conditions. PursueCare's business model is centered on partnerships with health systems, hospitals, community health centers, employers, and health plans, including Medicaid and Medicare, to integrate its virtual services and act as an in-network provider. This collaborative approach aims to create a seamless transition for patients from various settings, like emergency rooms, into a continuous care model.

The core of PursueCare's offering is its technology-enabled platform that provides patients with a multidisciplinary care team. This team includes addiction medicine providers, psychiatrists, counselors, therapists, and pharmacists. Key services include Medication-Assisted Treatment (MAT), personalized therapy and counseling, psychiatric care for dual diagnoses, and at-home lab testing. A distinguishing feature is its in-house, Joint Commission-accredited pharmacy, PursueCareRx, which allows for discreet home delivery of prescribed medications, including buprenorphine (Suboxone). In a significant milestone, PursueCare acquired the FDA-authorized digital therapeutics reSET® and reSET-O® in December 2023, which provide app-based cognitive behavioral therapy to support recovery. This acquisition, part of a $20 million Series B funding round, enhances the company's ability to offer a data-driven, value-based care model focused on improving patient outcomes and reducing healthcare costs.